Merck, NewLink nab up to $76M BARDA contract to back Ebola vaccine - FierceBiotech

FierceBiotech
Merck, NewLink nab up to $76M BARDA contract to back Ebola vaccine
FierceBiotech
Partners Merck ($MRK) and NewLink Genetics ($NLNK) have nabbed a $24.8 million contract to support the development of their Ebola vaccine. The candidate just won a breakthrough designation from the FDA and priority medicine status from the EMA in ...and more »